中文(繁體)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Perioperative Epidural Anesthesia and Analgesia on Gut Microbiota

只有註冊用戶可以翻譯文章
登陸註冊
鏈接已保存到剪貼板
狀態招聘中
贊助商
National Taiwan University Hospital

關鍵詞

抽象

As the only curative treatment for end-stage liver diseases, liver transplantation has been widely carried out around the world. The shortage of organs from deceased donors facilitate the adoption of living donor liver transplantation. Living donor hepatectomy is the most massive operation a healthy person could undergo, so donor safety is of utmost importance. However, previous studies focused on the outcomes of liver transplant recipients. There are still many uncertainties about the recovery in living liver donors.
The body microorganisms that reside in the human intestinal tract, referred to as the gut microbiota, are essential to human metabolism and immunity. The physiological functions of microbiota include defense against pathogens, providing nutrients such as vitamin B12 folate and vitamin K, and modulating gut integrity and permeability. Despite relatively stable microbiota during life, different illnesses, surgeries, medications dietary factors, and lifestyle changes could contribute to the imbalance of ecosystems resulting many gastrointestinal and extra-gastrointestinal disorders. Many researches have established a relationship between the gut microbiome and patients with liver disease such as liver cirrhosis, alcoholic liver disease and obesity related liver diseases etc. These liver disorders are associated with bacterial overgrowth, dysbiosis, and increased intestinal permeability. However, the relationship between hepatectomy and microbiota has not been fully investigated, especially in healthy liver donors.
Many routine perioperative management can impact the state of the microbiome and therefore can impact clinical outcomes, like bowel preparation and antibiotics. Potential factors affecting the gut microbiota also include perioperative manipulation, stress released hormones, and opioids. Maintenance of proper anesthetic depth is beneficial to attenuate surgical stress. However, general anesthesia including volatile anesthetics and opioids, is associated with altered gut microbiota. Therefore, regional anesthesia and analgesia which effectively attenuating surgical stress while efficiently reducing general anesthetics consumption, seem to provide promising advantages. Epidural analgesia has been proved to improve gastrointestinal function in major abdominal and thoracic surgery. However, the effect of perioperative epidural anesthesia and analgesia on microbiota is not clear.

日期

最後驗證: 07/31/2019
首次提交: 09/02/2019
提交的預估入學人數: 09/02/2019
首次發布: 09/05/2019
上次提交的更新: 09/30/2019
最近更新發布: 10/01/2019
實際學習開始日期: 09/29/2019
預計主要完成日期: 11/29/2021
預計完成日期: 12/30/2021

狀況或疾病

Living Donor Hepatectomy

干預/治療

Procedure: Patient controlled epidural analgesia

Drug: Intravenous patient controlled analgesia

-

手臂組

干預/治療
Active Comparator: Patient controlled epidural analgesia
Use of patient controlled epidural analgesia (PCEA) for postoperative pain control
Procedure: Patient controlled epidural analgesia
Patient controlled epidural analgesia with marcaine 0.66mg/ml +fentanyl 1.75mcg/ml for postoperative pain control
Sham Comparator: Intravenous patient controlled analgesia
Use of intravenous patient controlled analgesia(IVPCA) for postoperative pain control
Drug: Intravenous patient controlled analgesia
Intravenous patient controlled analgesia with morphine 1mg/ml for postoperative pain control

資格標準

有資格學習的年齡 20 Years 至 20 Years
有資格學習的性別All
接受健康志願者
標準

Inclusion Criteria:

1. Expected to receive living liver hepatectomy in National Taiwan University Hospital, age between 20 and 55 years old.

Exclusion Criteria:

1. Previous use of antibiotics within four weeks.

2. Previous gastrointestinal surgery.

結果

主要結果指標

1. Microbiota analysis [one month]

16S metagenomic sequence processing

次要成果指標

1. LPS-binding protein [one month]

LPS-binding protein(mcg/mL)

2. Intestinal fatty acid binding protein [one month]

Intestinal fatty acid binding protein(ng/mL)

3. IgA [one month]

IgA(mcg/mL)

4. IL-6 [one month]

IL-6(ng/mL)

5. I-FEED scoring [one week]

I-FEED scoring system for postoperative gastrointestinal function: Intake(score): tolerating oral diet(0), limited tolerance(1), complete Intolerance(3) Feeling nauseated(score): none(0), responsive to treatment(1), resistant to treatment(3) Emesis(score): none(0), ≧1 episode of low volume(<100mL) and none bilious(1), ≧1 episode of high volume(>100mL) or bilious(3) Exam(score): no distension(0), distension without tympany(1), significant distension with tympany(3) Duration of symptoms(score):0-24hours(0),24-72hours(1),>72hours(2) Total score: 0-2 normal, 3-5 postoperative GI intolerance, >6 postoperative GI dysfunction

加入我們的臉書專頁

科學支持的最完整的草藥數據庫

  • 支持55種語言
  • 科學支持的草藥療法
  • 通過圖像識別草藥
  • 交互式GPS地圖-在位置標記草藥(即將推出)
  • 閱讀與您的搜索相關的科學出版物
  • 通過藥效搜索藥草
  • 組織您的興趣並及時了解新聞研究,臨床試驗和專利

輸入症狀或疾病,並閱讀可能有用的草藥,輸入草藥並查看其所針對的疾病和症狀。
*所有信息均基於已發表的科學研究

Google Play badgeApp Store badge